{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T16:29:33Z","timestamp":1772641773210,"version":"3.50.1"},"reference-count":9,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["annallergy.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Allergy, Asthma & Immunology"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.anai.2022.04.031","type":"journal-article","created":{"date-parts":[[2022,5,7]],"date-time":"2022-05-07T11:14:00Z","timestamp":1651922040000},"page":"254-255","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Treatment of a 4-year-old boy with mepolizumab for lymphocytic hypereosinophilic syndrome"],"prefix":"10.1016","volume":"129","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3582-2082","authenticated-orcid":false,"given":"Jason A.","family":"Cascio","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Madalyn","family":"Walsh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kelly","family":"Hoenig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin","family":"Davis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.anai.2022.04.031_bib0001","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1056\/NEJMoa070812","article-title":"Treatment of patients with the hypereosinophilic syndrome with mepolizumab","volume":"358","author":"Rothenberg","year":"2008","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.anai.2022.04.031_bib0002","doi-asserted-by":"crossref","first-page":"e34","DOI":"10.1164\/rccm.201907-1376IM","article-title":"The effect of mepolizumab on the lungs in a boy with hypereosinophilic syndrome","volume":"202","author":"Armoni Domany","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.anai.2022.04.031_bib0003","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/pai.12809","article-title":"Mepolizumab-a novel option for the treatment of hypereosinophilic syndrome in childhood","volume":"29","author":"Schwarz","year":"2018","journal-title":"Pediatr Allergy Immunol"},{"issue":"10","key":"10.1016\/j.anai.2022.04.031_bib0004","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/j.leukres.2012.05.025","article-title":"Hypereosinophilic syndrome in children","volume":"36","author":"van Grotel","year":"2012","journal-title":"Leuk Res"},{"issue":"3","key":"10.1016\/j.anai.2022.04.031_bib0005","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/j.jaip.2021.10.064","article-title":"Pediatric eosinophilic bronchiolitis successfully treated with mepolizumab","volume":"10","author":"Arceri","year":"2022","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"6","key":"10.1016\/j.anai.2022.04.031_bib0006","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1016\/j.jaci.2013.02.042","article-title":"Anti-IL-5 therapy reduces mast cell and IL-9 cell numbers in pediatric patients with eosinophilic esophagitis","volume":"131","author":"Otani","year":"2013","journal-title":"J Allergy Clin Immunol"},{"issue":"8","key":"10.1016\/j.anai.2022.04.031_bib0007","doi-asserted-by":"crossref","first-page":"2750","DOI":"10.1016\/j.jaip.2019.05.011","article-title":"Pediatric hypereosinophilia: characteristics, clinical manifestations, and diagnoses","volume":"7","author":"Burris","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"10","key":"10.1016\/j.anai.2022.04.031_bib0008","first-page":"2316","article-title":"Hypereosinophilia-an unusual cause of multiple embolic strokes and multi-organ dysfunction","volume":"7","author":"Khwaja","year":"2013","journal-title":"J Clin Diagn Res"},{"issue":"1","key":"10.1016\/j.anai.2022.04.031_bib0009","doi-asserted-by":"crossref","first-page":"118","DOI":"10.4103\/aian.AIAN_261_19","article-title":"Hypereosinophilia as a cause of recurrent stroke","volume":"23","author":"Venkatakrishnan","year":"2020","journal-title":"Ann Indian Acad Neurol"}],"container-title":["Annals of Allergy, Asthma & Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120622003994?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120622003994?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T13:30:01Z","timestamp":1761053401000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1081120622003994"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":9,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["S1081120622003994"],"URL":"https:\/\/doi.org\/10.1016\/j.anai.2022.04.031","relation":{},"ISSN":["1081-1206"],"issn-type":[{"value":"1081-1206","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment of a 4-year-old boy with mepolizumab for lymphocytic hypereosinophilic syndrome","name":"articletitle","label":"Article Title"},{"value":"Annals of Allergy, Asthma & Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anai.2022.04.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 American College of Allergy, Asthma & Immunology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}